Docs want FDA to ease CV rules for diabetes drugs

Three cardiologists asked FDA in a New England Journal of Medicine Avandia rosiglitazone from GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) (see BioCentury, March 10, 2008). ...